Clear cell renal cell carcinoma ontogeny and mechanisms of lethality

E Jonasch, CL Walker, WK Rathmell - Nature Reviews Nephrology, 2021 - nature.com
The molecular features that define clear cell renal cell carcinoma (ccRCC) initiation and
progression are being increasingly defined. The TRACERx Renal studies and others that …

Sarcomatoid renal cell carcinoma: biology, natural history and management

KA Blum, S Gupta, SK Tickoo, TA Chan… - Nature Reviews …, 2020 - nature.com
Sarcomatoid dedifferentiation is an uncommon feature that can occur in most histological
subtypes of renal cell carcinomas (RCCs) and carries a decidedly poor prognosis …

[HTML][HTML] New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

K Trpkov, O Hes, SR Williamson, AJ Adeniran… - Modern Pathology, 2021 - Elsevier
Abstract The Genitourinary Pathology Society (GUPS) reviewed recent advances in renal
neoplasia, particularly post-2016 World Health Organization (WHO) classification, to provide …

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

JA Flores-Toro, D Luo, A Gopinath… - Proceedings of the …, 2020 - National Acad Sciences
Immunotherapy directed at the PD-L1/PD-1 axis has produced treatment advances in
various human cancers. Unfortunately, progress has not extended to glioblastoma (GBM) …

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Z Bakouny, DA Braun, SA Shukla, W Pan, X Gao… - Nature …, 2021 - nature.com
Sarcomatoid and rhabdoid (S/R) renal cell carcinoma (RCC) are highly aggressive tumors
with limited molecular and clinical characterization. Emerging evidence suggests immune …

[HTML][HTML] Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma

BI Rini, S Signoretti, TK Choueiri… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Patients with advanced renal cell carcinoma with sarcomatoid features (sRCC)
have a poor prognosis and limited therapeutic options. First-line nivolumab plus ipilimumab …

[HTML][HTML] Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell …

W Xu, WR Liu, Y Xu, X Tian, A Anwaier… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Purpose: This study aimed to identify the potential prognostic role of HK3 and provide clues
about glycolysis and the microenvironmental characteristics of ccRCC. Methods: Based on …

[HTML][HTML] HHLA2 and PD-L1 co-expression predicts poor prognosis in patients with clear cell renal cell carcinoma

QH Zhou, KW Li, X Chen, HX He, SM Peng… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Although clear cell renal cell carcinoma (ccRCC) is well known as a highly
immunogenic tumor, only a small subset of patients could benefit from current …

Quantitative analysis of immune infiltrates in primary melanoma

RD Gartrell, DK Marks, TD Hart, G Li, DR Davari… - Cancer immunology …, 2018 - AACR
Novel methods to analyze the tumor microenvironment (TME) are urgently needed to stratify
melanoma patients for adjuvant immunotherapy. Tumor-infiltrating lymphocyte (TIL) …

Calpain2 Upregulation Regulates EMT-Mediated Pancreatic Cancer Metastasis via the Wnt/β-Catenin Signaling Pathway

X Peng, R Yang, J Song, X Wang, W Dong - Frontiers in medicine, 2022 - frontiersin.org
Calpains2 (CAPN2) is a calcium-dependent, non-lysosomal cysteine protease that plays
critical roles in normal cellular functions and pathological processes, including …